Tong Ren Tang Technologies Co Ltd Class H (DE:TNG)
FRANKFURT:TNG
TNG Stock Chart & Stats
€0.50
-€0.03(-4.07%)
At close: 4:00 PM EST
€0.50
-€0.03(-4.07%)
Day’s Range― - ―
52-Week Range€0.34 - €0.60
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€501.19M
Enterprise Value€1.21B
Total Cash (Recent Filing)€4.84B
Total Debt (Recent Filing)€2.17B
Price to Earnings (P/E)9.4
Beta0.61
Next Earnings
Aug 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.30
Shares Outstanding628,704,000
10 Day Avg. Volume2
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)0.69
Price to Sales (P/S)0.78
P/FCF Ratio3.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.58Price Target Upside15.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.04
Revenue Forecast (FY)€765.24M
Bulls Say, Bears Say
Bulls Say
Strong TCM BrandTong Ren Tang's recognized TCM brand and heritage provide durable competitive advantage in trust-driven healthcare products. Brand equity supports premium positioning, channel access and repeat customer demand, underpinning sustainable revenue sources and resilience versus newer entrants.
Improving Balance SheetLeverage reduction and steady equity growth signal stronger financial flexibility and lower balance-sheet risk. A contained debt-to-equity (~0.30) supports investment, working-capital management and capacity to withstand shocks without resorting to dilutive financing.
2025 Cash-flow ReboundA strong operating cash-flow and positive free cash flow in 2025 materially improves the company's ability to self-fund capex, R&D and distributions. Robust FCF enhances strategic optionality and reduces near-term reliance on external funding for growth initiatives.
Bears Say
Revenue DeclineA meaningful revenue contraction (-9.1% in 2025) indicates weakening end-market demand or loss of momentum. Sustained top-line decline compresses operating leverage, limits reinvestment capacity and raises strategic urgency to restore growth over the medium term.
Margin CompressionSequential margin erosion at both gross and net levels points to cost or pricing pressure that erodes profitability. Even with positive EBIT/EBITDA margins, declining margins weaken return on capital and could force either cost restructuring or margin recovery initiatives.
Volatile Cash ConversionExtreme swings in cash conversion across years indicate working-capital sensitivity and unpredictable cash generation. Such volatility complicates forecasting, increases financing risk during downturns and undermines confidence in sustaining investment or payout policies.
Tong Ren Tang Technologies Co News
TNG FAQ
What was Tong Ren Tang Technologies Co Ltd Class H’s price range in the past 12 months?
Tong Ren Tang Technologies Co Ltd Class H lowest stock price was €0.34 and its highest was €0.60 in the past 12 months.
What is Tong Ren Tang Technologies Co Ltd Class H’s market cap?
Tong Ren Tang Technologies Co Ltd Class H’s market cap is €501.19M.
When is Tong Ren Tang Technologies Co Ltd Class H’s upcoming earnings report date?
Tong Ren Tang Technologies Co Ltd Class H’s upcoming earnings report date is Aug 20, 2026 which is in 64 days.
How were Tong Ren Tang Technologies Co Ltd Class H’s earnings last quarter?
Tong Ren Tang Technologies Co Ltd Class H released its earnings results on Mar 27, 2026. The company reported €0.005 earnings per share for the quarter, beating the consensus estimate of N/A by €0.005.
Is Tong Ren Tang Technologies Co Ltd Class H overvalued?
According to Wall Street analysts Tong Ren Tang Technologies Co Ltd Class H’s price is currently Undervalued.
Does Tong Ren Tang Technologies Co Ltd Class H pay dividends?
Tong Ren Tang Technologies Co Ltd Class H does not currently pay dividends.
What is Tong Ren Tang Technologies Co Ltd Class H’s EPS estimate?
Tong Ren Tang Technologies Co Ltd Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tong Ren Tang Technologies Co Ltd Class H have?
Tong Ren Tang Technologies Co Ltd Class H has 628,704,000 shares outstanding.
What happened to Tong Ren Tang Technologies Co Ltd Class H’s price movement after its last earnings report?
Tong Ren Tang Technologies Co Ltd Class H reported an EPS of €0.005 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.75%.
Which hedge fund is a major shareholder of Tong Ren Tang Technologies Co Ltd Class H?
Currently, no hedge funds are holding shares in DE:TNG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tong Ren Tang Technologies Co Ltd Class H
Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.
TNG Stock 12 Month Forecast
Average Price Target
€0.58
▲(15.71% Upside)
Technical Analysis
Beijing Tong Ren Tang Chinese Medicine Co
―
China Traditional Chinese Medicine Holdings Co
―
CSPC Pharmaceutical Group
―
Wai Yuen Tong Medicine Holdings Limited
―
Pak Fah Yeow International Limited
―
Options Prices
Currently, No data available
---